Oligonucleotide Synthesis Market: Rising Demand for Precision Medicine and Molecular Research
Polaris Market Research today announced findings from its
latest report, projecting the global
Oligonucleotide Synthesis Market to grow from USD 3.55 billion in 2025
to USD 12.49 billion by 2034, at a CAGR of 15.01% between 2026 and 2034. The
report profiles 14 leading companies across five market segments: product,
application, end user, technology or chemistry, and region.
Analyst Commentary on Oligonucleotide Synthesis Market
Growth
“Oligonucleotide-based medicines are moving from niche to
mainstream, and that shift is lifting demand for custom synthesis,
purification, and manufacturing capacity across the industry,” said a senior
analyst at Polaris Market Research. “The opportunity lies with service
providers and CDMOs that can deliver longer, modified sequences at scale as
enzymatic synthesis and automation mature.”
The market is estimated at USD 4.07 billion in 2026.
Services was the largest product segment in 2025 with 38.24% of revenue, as
pharmaceutical, biotechnology, and research organizations increasingly
outsource synthesis and purification instead of investing in in-house
production systems. Several companies have also secured regulatory
accreditation for their manufacturing facilities.
Oligonucleotide Synthesis Market Statistics at a Glance
- 2025
Market Size: USD 3.55 Billion
- 2034
Projected Size: USD 12.49 Billion
- CAGR
(2026-2034): 15.01%
- Largest
Region (2025): North America, 40.9% share
Key Growth Drivers, Major Companies and Segments Covered
Growth Drivers: Rising demand for
oligonucleotide-based medicines, growing investment in advanced manufacturing,
and wider use in molecular diagnostics and genetic testing are the primary
forces behind the market's expansion, alongside growing demand for siRNA and
antisense therapeutics. In 2026, Aragen Life Sciences announced plans to add
500 kiloliters of new CDMO capacity, with oligonucleotides among its focus
areas. High manufacturing complexity, especially for longer and modified
sequences, remains the main restraint.
Major Companies Covered: Agilent Technologies, Thermo
Fisher Scientific, Merck KGaA, GenScript Biotech, Integrated DNA Technologies,
Eurofins Genomics, LGC Biosearch Technologies, TriLink BioTechnologies, and
Twist Bioscience, among others.
Segments Covered: By Product (Synthesized
Oligonucleotide Products, Equipment, Reagents, Services), By Application (PCR
Primers, PCR Assays and Panels, DNA Microarrays, Sequencing, Antisense
Oligonucleotides, FISH), By End User, By Technology/Chemistry (Phosphoramidite
Chemistry, Solid-Phase Synthesis, Liquid-Phase Synthesis, Enzymatic Synthesis),
By Region.
👉 Download a Free
Sample of the Oligonucleotide Synthesis Market Report →
https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market
Segment Insights: PCR Primers, Academic Users, and
Solid-Phase Chemistry Lead
PCR primers led applications with 20.4% of revenue in 2025,
while antisense oligonucleotides are projected to grow at a 15.9% CAGR through
2034. Academic and research institutes were the largest end user with 44.9% of
revenue, whereas pharmaceutical and biotechnology companies are expected to
grow at a 16.5% CAGR.
Chemical and solid-phase synthesis held 66.2% of revenue in
2025 and remains the dominant technology. Enzymatic synthesis, however, is
projected to expand at an 18.6% CAGR as demand rises for longer and more
complex sequences in gene editing, cell therapy, and synthetic biology.
Technology is reshaping production economics. Automation and
high-throughput systems allow laboratories to process more sequences with less
manual work, while AI-assisted sequence design and improved purification help
developers handle complex oligonucleotides. In February 2026, the FDA launched
a framework for individualized therapies for ultra-rare diseases, opening new
avenues for customized nucleic acid medicines.
Recent Developments in the Oligonucleotide Synthesis
Market
- July
2026: DNA Script signed a distribution agreement with Imperial Life
Sciences to expand access to its SYNTAX on-demand DNA synthesis platform
in India.
- July
2026: Oligo Factory launched NGS Unique-Dual Indexed Stubby Adapter Kits
to support next-generation sequencing workflows.
- July
2025: AstraZeneca announced plans to invest USD 50 billion in the U.S. by
2030, including a large-scale Virginia facility for small molecules,
peptides, and oligonucleotides.
- 2026:
Agilent launched Agilent Advanced Therapeutics to unify its CDMO
capabilities, including oligonucleotide manufacturing, across North
America.
- May
2025: Oligo Factory launched a low-scale oligo synthesis capability at its
Holliston, Massachusetts facility to broaden support for therapeutic and
diagnostic developers.
Regional Snapshot: North America Leads, Asia Pacific
Fastest-Growing
North America led with 40.9% share in 2025, supported by a
prominent pharmaceutical and biotechnology sector, substantial R&D
investment, and rising genomic and gene therapy activity, while Asia Pacific is
projected to register the fastest CAGR of 17.5% through 2034 on the back of
growing biotechnology investment, genomics research, and personalized medicine,
with China, Japan, and India seeing increased activity.
Why It Matters for Buyers Evaluating the Oligonucleotide
Synthesis Market Forecast
For stakeholders researching top oligonucleotide synthesis
companies and the
oligonucleotide synthesis market forecast to 2034, the underlying report
benchmarks Oligonucleotide Synthesis Market share, company positioning, and
segment-level forecasts to support sourcing, partnership, and investment
decisions through 2034.
The market remains fragmented, with companies competing on
synthesis quality, purification capabilities, and regulator-accredited
manufacturing. Use cases span PCR testing, cancer biomarker detection, CRISPR
gene editing, drug discovery, and infectious disease testing, giving suppliers
multiple routes to growth through 2034.
About Polaris Market Research
Polaris Market Research is a B2B syndicated market research
and consulting firm offering 5,000+ published reports across 20+ industry
verticals, delivering data-backed insights to help businesses make informed
decisions.
More Trending Latest Reports By Polaris Market Research:
variable-frequency-drive-market
https://www.polarismarketresearch.com/press-releases/it-services-market
synthetic-data-generation-market
Comments
Post a Comment